119 related articles for article (PubMed ID: 8230020)
1. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury.
Lohmander LS; Hoerrner LA; Dahlberg L; Roos H; Björnsson S; Lark MW
J Rheumatol; 1993 Aug; 20(8):1362-8. PubMed ID: 8230020
[TBL] [Abstract][Full Text] [Related]
2. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Lohmander LS; Hoerrner LA; Lark MW
Arthritis Rheum; 1993 Feb; 36(2):181-9. PubMed ID: 8431206
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
[TBL] [Abstract][Full Text] [Related]
5. Cartilage metabolism in the injured and uninjured knee of the same patient.
Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
[TBL] [Abstract][Full Text] [Related]
6. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
Lohmander LS; Saxne T; Heinegård DK
Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
[TBL] [Abstract][Full Text] [Related]
7. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
[TBL] [Abstract][Full Text] [Related]
8. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
Lohmander LS; Atley LM; Pietka TA; Eyre DR
Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
[TBL] [Abstract][Full Text] [Related]
9. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
10. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
Shinmei M; Kobayashi T; Yoshihara Y; Samura A
J Rheumatol Suppl; 1995 Feb; 43():78-81. PubMed ID: 7752146
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
Lohmander LS; Saxne T; Heinegård D
Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
[TBL] [Abstract][Full Text] [Related]
12. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Walakovits LA; Moore VL; Bhardwaj N; Gallick GS; Lark MW
Arthritis Rheum; 1992 Jan; 35(1):35-42. PubMed ID: 1370619
[TBL] [Abstract][Full Text] [Related]
13. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
Chockalingam PS; Glasson SS; Lohmander LS
Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Synovial Fluid Biomarkers With Cartilage Pathology and Associated Outcomes in Knee Arthroscopy.
Cuéllar VG; Cuéllar JM; Kirsch T; Strauss EJ
Arthroscopy; 2016 Mar; 32(3):475-85. PubMed ID: 26524935
[TBL] [Abstract][Full Text] [Related]
16. Markers of joint tissue turnover in joint fluids from hips with osteonecrosis of the femoral head.
Jingushi S; Lohmander LS; Shinmei M; Hoerrner LA; Lark MW; Sugioka Y; Iwamoto Y
J Orthop Res; 2000 Sep; 18(5):728-33. PubMed ID: 11117293
[TBL] [Abstract][Full Text] [Related]
17. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.
Roos H; Dahlberg L; Hoerrner LA; Lark MW; Thonar EJ; Shinmei M; Lindqvist U; Lohmander LS
Osteoarthritis Cartilage; 1995 Mar; 3(1):7-14. PubMed ID: 7719956
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of proteoglycan fragments in knee joint fluid after injury.
Lohmander LS; Dahlberg L; Ryd L; Heinegård D
Arthritis Rheum; 1989 Nov; 32(11):1434-42. PubMed ID: 2554931
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human interleukin-1 beta-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid.
McDonnell J; Hoerrner LA; Lark MW; Harper C; Dey T; Lobner J; Eiermann G; Kazazis D; Singer II; Moore VL
Arthritis Rheum; 1992 Jul; 35(7):799-805. PubMed ID: 1320383
[TBL] [Abstract][Full Text] [Related]
20. Role of metalloproteinases in human osteoarthritis.
Woessner JF; Gunja-Smith Z
J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
